
Nova Eye Medical
(ASX) EYE
Nova Eye Medical Financials at a Glance
Market Cap
A$34.18M
Revenue (TTM)
A$59.16M
Net Income (TTM)
-A$15.59M
EPS (TTM)
-A$0.02
P/E Ratio
-4.82
Dividend
A$0.00
Beta (Volatility)
0.25 (Low)
Dividend
A$0.00
Beta (Volatility)
0.25 (Low)
Price
A$0.12
Volume
174,400
Open
A$0.11
Price
A$0.12
Volume
174,400
Open
A$0.11
Previous Close
A$0.12
Daily Range
A$0.11 - A$0.12
52-Week Range
A$0.10 - A$0.21
Estimated Earnings Date
Aug 26, 2026
Dividend
A$0.00
Beta (Volatility)
0.25 (Low)
Price
A$0.12
Volume
174,400
Open
A$0.11
Previous Close
A$0.12
Daily Range
A$0.11 - A$0.12
52-Week Range
A$0.10 - A$0.21
Estimated Earnings Date
Aug 26, 2026
EYE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nova Eye Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareCEO
Thomas Spurling
Website
www.nova-eye.comHeadquarters
Kent Town, SA 5067, AU
EYE Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
-16%
Net Income Margin
-21%
Return on Equity
-42%
Return on Capital
-29%
Return on Assets
-30%
Earnings Yield
-20.75%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
A$34.18M
Shares Outstanding
284.87M
Volume
174.40K
Avg. Volume
266.08K
Financials (TTM)
Gross Profit
A$20.07M
Operating Income
-A$11.25M
EBITDA
-A$8.99M
Operating Cash Flow
-A$6.15M
Capital Expenditure
-A$426.00K
Free Cash Flow
-A$6.58M
Cash & ST Invst.
A$5.06M
Total Debt
A$3.02M
Nova Eye Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$16.71M
+64.8%
Gross Profit
A$11.72M
+786.3%
Gross Margin
70.11%
N/A
Market Cap
A$34.18M
N/A
Market Cap/Employee
A$113.57K
N/A
Employees
301
N/A
Net Income
-A$3.37M
+40.2%
EBITDA
-A$2.36M
+43.5%
Quarterly Fundamentals
Total Cash
A$2.62M
+0.4%
Total Debt
A$4.94M
+306.6%
Accounts Receivable
A$4.10M
+85.8%
Inventory
A$3.50M
-15.3%
Long Term Debt
A$4.29M
+668.2%
Short Term Debt
A$646.00K
-50.8%
Return on Assets
-29.70%
N/A
Return on Invested Capital
-29.00%
N/A
Free Cash Flow
-A$2.41M
+46.1%
Operating Cash Flow
-A$2.28M
+44.7%